表紙
市場調査レポート

尿道スリングの米国市場 (2015〜2019年)

Urinary Slings Market in the US 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 328088
出版日 ページ情報 英文 95 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
尿道スリングの米国市場 (2015〜2019年) Urinary Slings Market in the US 2015-2019
出版日: 2015年04月08日 ページ情報: 英文 95 Pages
概要

尿失禁スリングとは、外科手術により尿道を正常な位置に戻して失禁を効果的に抑制するための、柔軟なメッシュシステムです。スリング処置では、人体組織の切片や剛性メッシュを用いて、膀胱頚部を包み込むようなハンモック状の固定物や、尿を膀胱へと流す管を設置します。尿失禁スリングには、TOT (経閉鎖孔) スリングとTVT (無緊張型膣テープ) スリングの2種類があり、どちらも腹圧性尿失禁 (SUI) の外科治療に用いられています。米国の尿道スリング市場は2014〜2019年にかけて、11.85%の年平均成長率 (CAGR) で成長する見通しです。

当レポートでは、米国における尿道スリングの市場について分析し、市場の概要や構造、市場規模の動向 (今後5年間の予測値)、地域別の詳細動向、市場の促進・抑制要因とその影響力、主要企業のプロファイル、今後の市場機会などを調査・考察しております。

第1章 エグゼクティブサマリー

第2章 略語集

第3章 分析範囲

  • 市場概要
  • 主な製品

第4章 市場分析の手法

  • 市場分析のプロセス
  • 分析手法

第5章 イントロダクション

第6章 尿道スリングを使用する適応症

  • 尿失禁
  • 尿失禁の種類
    • 緊張性尿失禁
    • 切迫尿失禁
    • 混合性尿失禁
    • 機能性尿失禁
    • 溢流性尿失禁
  • 骨盤臓器脱
  • 過活動膀胱
  • 尿失禁の治療技術

第7章 腹圧性尿失禁 (SUI)

  • 患者のプロファイル
  • 治療法の比較

第8章 市場環境

  • 市場概況
  • 市場規模とその予測
  • ファイブフォース分析

第9章 種類別の市場区分

  • 膣スリング
  • 男性用スリング
  • 米国の膣スリング市場
  • 米国の男性用スリング市場

第10章 米国の膣スリング市場

  • 尿道下スリング
  • 単孔式スリング (Single-incision Slings)
  • 米国のTOT (経閉鎖孔) スリング市場
  • 米国のTVT (無緊張型膣テープ) スリング市場
  • 米国の単孔式スリング市場

第11章 米国の男性用スリング市場

第12章 医療費償還シナリオ

第13章 購入基準

第14章 市場の成長促進要因

第15章 促進要因とその影響力

第16章 市場の課題

第17章 促進要因・課題の影響力

第18章 市場の傾向

第19章 市場動向とその影響

第20章 ベンダー環境

  • 競争シナリオ
  • 市場シェア分析
  • その他の著名なベンダー

第21章 主要ベンダーの分析

  • American Medical Systems
    • 主要データ
    • 事業概要
    • 主要ブランド
    • 治療領域
    • 世界各地への事業展開
    • 事業戦略
    • 最近の発展動向
    • SWOT分析
  • Boston Scientific
  • Coloplast
  • C. R. Bard
  • Johnson & Johnson

第22章 関連レポート

図表一覧

目次
Product Code: IRTNTR5653

About Urinary Incontinence Slings

Urinary incontinence slings are flexible surgical mesh systems that are placed surgically to restore the urethra to its normal position and efficiently minimize incontinence. A sling procedure uses strips of the body's tissue or synthetic mesh to create a hammock-like fixture that wraps around the bladder neck and a tube that transports urine from the bladder. Urinary incontinence slings are also called urethral support slings. Urinary slings are of two major types: trans obturator tape sling and tension-free vaginal tape sling. These slings are used in the surgical incontinence for treating stress urinary incontinence.

TechNavio's analysts forecast the Urinary Slings market in the US to grow at a CAGR of 11.85 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Urinary Slings market in the US for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of different types of urinary slings. Urinary slings have been segmented into the following:

  • Vaginal Slings (TVT, TOT, and Single-incision)
  • Male Slings (Artificial Urinary Sphincters)

TechNavio's report, the Urinary Slings Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It also covers the landscape of the Urinary Slings market in the US and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Country

  • US

Key Vendors

  • American Medical System
  • Boston Scientific
  • Coloplast
  • C.R. Bard
  • Ethicon (Johnson & Johnson)

Other Prominent Vendors

  • Caldera Medical
  • Cook Medical
  • Covidien
  • Organogenesis
  • Prosurg
  • Sofradim
  • Surgicraft
  • Uroplasty

Market Driver

  • Growing Aging Population
  • For a full, detailed list, view our report

Market Challenge

  • Risk and Complication Related with Sling Procedures
  • For a full, detailed list, view our report

Market Trend

  • Demand for Single-incision Slings
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Indications for Use of Urinary Slings

  • 06.1. Urinary Incontinence
  • 06.2. Types of Urinary Incontinence
    • 06.2.1. Stress Incontinence
    • 06.2.2. Urge Incontinence
    • 06.2.3. Mixed Incontinence
    • 06.2.4. Functional Incontinence
    • 06.2.5. Overflow Incontinence
  • 06.3. Pelvic Organ Prolapse
  • 06.4. Overactive Bladder
  • 06.5. Treatment Techniques for Urinary Incontinence

07. SUI

  • 07.1. Patient Profile
  • 07.2. Treatment Comparison

08. Market Landscape

  • 08.1. Market Overview
  • 08.2. Market Size and Forecast
  • 08.3. Five Forces Analysis

09. Market Segmentation by Type

  • 09.1. Vaginal Slings
  • 09.2. Male Slings
  • 09.3. Vaginal Slings Market in US
    • 09.3.1. Market Size and Forecast
  • 09.4. Male Slings Market in US
    • 09.4.1. Market Size and Forecast

10. Vaginal Slings Market in US

  • 10.1. Mid-Urethral Slings
  • 10.2. Single-incision Slings
  • 10.3. TOT Slings Market in US
    • 10.3.1. Market Size and Forecast
  • 10.4. TVT Slings Market in US
    • 10.4.1. Market Size and Forecast
  • 10.5. Single-incision Slings Market in US
    • 10.5.1. Market Size and Forecast

11. Male Slings Market in the US

    • 11.1.1. Market Size and Forecast

12. Reimbursement Scenario

13. Buying Criteria

14. Market Growth Drivers

15. Drivers and their Impact

16. Market Challenges

17. Impact of Drivers and Challenges

18. Market Trends

19. Trends and their Impact

20. Vendor Landscape

  • 20.1. Competitive Scenario
  • 20.2. Market Share Analysis 2014
  • 20.3. Other Prominent Vendors

21. Key Vendor Analysis

  • 21.1. American Medical Systems
    • 21.1.1. Key Facts
    • 21.1.2. Business Overview
    • 21.1.3. Key Brands
    • 21.1.4. Therapeutic Areas
    • 21.1.5. Geographical Segmentation
    • 21.1.6. Business Strategy
    • 21.1.7. Recent Developments
    • 21.1.8. SWOT Analysis
  • 21.2. Boston Scientific
    • 21.2.1. Key Facts
    • 21.2.2. Business Overview
    • 21.2.3. Key Products
    • 21.2.4. Key Products in Cardiovascular Segment
    • 21.2.5. Key Products in MedSurg Segment
    • 21.2.6. Key Products in Rhythm Management Segment
    • 21.2.7. Business Segmentation by Revenue 2013
    • 21.2.8. Business Segmentation by Revenue 2012 and 2013
    • 21.2.9. Geographical Segmentation by Revenue 2013
    • 21.2.10. Business Strategy
    • 21.2.11. Recent Developments
    • 21.2.12. SWOT Analysis
  • 21.3. Coloplast
    • 21.3.1. Key Facts
    • 21.3.2. Business Overview
    • 21.3.3. Business Segmentation by Revenue 2014
    • 21.3.4. Business Segmentation by Revenue 2013 and 2014
    • 21.3.5. Geographical Segmentation by Revenue 2014
    • 21.3.6. Business Strategy
    • 21.3.7. Key Developments
    • 21.3.8. SWOT Analysis
  • 21.4. C. R. Bard
    • 21.4.1. Key Facts
    • 21.4.2. Business Overview
    • 21.4.3. Product Segmentation by Revenue 2013
    • 21.4.4. Product Segmentation by Revenue 2012 and 2013
    • 21.4.5. Geographical Segmentation by Revenue 2013
    • 21.4.6. Business Strategy
    • 21.4.7. Recent Developments
    • 21.4.8. SWOT Analysis
  • 21.5. Johnson & Johnson
    • 21.5.1. Key Facts
    • 21.5.2. Business Overview
    • 21.5.3. Business Segmentation by Revenue 2013
    • 21.5.4. Business Segmentation by Revenue 2012 and 2013
    • 21.5.5. Geographical Segmentation by Revenue 2013
    • 21.5.6. Business Strategy
    • 21.5.7. Recent Developments
    • 21.5.8. SWOT Analysis

22. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Types of Urinary Incontinence and Prevalence
  • Exhibit 3: Urinary Slings Market in US 2014-2019 (US$ million)
  • Exhibit 4: Urinary Slings Segmentation by Type
  • Exhibit 5: Segmentation of Urinary Slings Market in US by Type 2014
  • Exhibit 6: Vaginal Slings Market in US 2014-2019 (US$ million)
  • Exhibit 7: Male Slings Market in US 2014-2019 (US$ million)
  • Exhibit 8: Segmentation of Urinary Slings Market in US by Type 2014-2019 (US$ million)
  • Exhibit 9: Segmentation of Urinary Slings Market in US by Gender 2014-2019
  • Exhibit 10: Segmentation of Urinary Slings Market in US by Type 2014-2019 (US$ million)
  • Exhibit 11: Segmentation of Urinary Slings Market in the US by Type 2014-2019
  • Exhibit 12: YOY Growth Rates for Urinary Slings Market in US
  • Exhibit 13: Segmentation of Vaginal Slings Market in US by Procedure
  • Exhibit 14: TOT Slings Market in US 2014-2019 (US$ million)
  • Exhibit 15: TVT Slings Market in US 2014-2019 (US$ million)
  • Exhibit 16: Single-incision Market in US 2014-2019 (US$ million)
  • Exhibit 17: Male Slings Market in US 2014-2019 (US$ million)
  • Exhibit 18: Reimbursement for Slings (Medicare)
  • Exhibit 19: Slings RVUs (Medicare)
  • Exhibit 20: ICD Diagnosis Codes for Slings
  • Exhibit 21: Urinary Incontinence in Women in US 2014
  • Exhibit 22: Urinary Incontinence in Men in US 2014
  • Exhibit 23: Per Capita Healthcare Expenditure in Top 10 Countries 2010-2013 (US$)
  • Exhibit 24: Per Capita Healthcare Expenditure in Top 10 Countries 2010-2013
  • Exhibit 25: American Medical Systems: Key Brands
  • Exhibit 26: American Medical Systems: Therapeutic Areas
  • Exhibit 27: American Medical Systems: Geographical Segmentation
  • Exhibit 28: Boston Scientific: Key Products in Cardiovascular Segment
  • Exhibit 29: Boston Scientific: Key Products in MedSurg Segment
  • Exhibit 30: Boston Scientific: Key Products in Rhythm Management Segment
  • Exhibit 31: Boston Scientific: Business Segmentation by Revenue 2013
  • Exhibit 32: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 33: Boston Scientific: Geographical Segmentation by Revenue 2013
  • Exhibit 34: Coloplast: Business Segmentation by Revenue 2014
  • Exhibit 35: Coloplast: Business Segmentation by Revenue 2013 and 2014 (US$ million)
  • Exhibit 36: Coloplast: Geographical Segmentation by Revenue 2014
  • Exhibit 37: C. R. Bard: Product Segmentation by Revenue 2013
  • Exhibit 38: C. R. Bard: Product Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 39: C. R. Bard: Geographical Segmentation by Revenue 2013
  • Exhibit 40: Johnson & Johnson: Business Segmentation by Revenue 2013
  • Exhibit 41: Johnson & Johnson: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 42: Johnson & Johnson: Geographical Segmentation by Revenue 2013
Back to Top